tm
Seeing Is Believing
tm
Seeing Is Believing
SPRY is currently covered by 3 analysts with an average price target of $31.27. This is a potential upside of $13.42 (75.18%) from yesterday's end of day stock price of $17.85.
ARS Pharmaceuticals's activity chart (see below) currently has 5 price targets and 15 ratings on display. The stock rating distribution of SPRY is 81.82% BUY and 18.18% HOLD.
Analysts average stock forecasts to be materialized ratio is 43.75% with an average time for these price targets to be met of 198 days.
Highest price target for SPRY is $30, Lowest price target is $30, average price target is $24.5.
Most recent stock forecast was given by JOSH SCHIMMER from CANTOR FITZGERALD on 08-Oct-2024. First documented stock forecast 31-Jan-2023.
Currently out of the existing stock ratings of SPRY, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$30
$12.08 (67.41%)
$30
9 months 13 days ago
(08-Oct-2024)
0/4 (0%)
$16.12 (116.14%)
Buy
$19
$1.08 (6.03%)
$13
1 years 4 months 10 days ago
(11-Mar-2024)
7/8 (87.5%)
$10.71 (129.19%)
396
What is SPRY (ARS Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on SPRY (ARS Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on SPRY (ARS Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SPRY (ARS Pharmaceuticals)?
Which analyst is the currently most bullish on SPRY (ARS Pharmaceuticals)?
Which analyst is the currently most reserved on SPRY (ARS Pharmaceuticals)?
